$IONS News Article - Akcea and Ionis Announce Initiation of NEURO-TTRansform Phase 3 Clinical Trial for AKCEA-TTR-LRx in Patients with Polyneuropathy Driven by Hereditary TTR Amyloidosis https://marketwirenews.com/news-releases/akce...25026.html
(0)
(0)
Ionis Pharmaceuticals, Inc. (IONS) Stock Research Links